declares having received honoraria from Akebia, Alnylam, Ardelyx, Becton Dickinson, Brainstorm Cell, Eli Lilly, Endologix, FibroGen, GlaxoSmithKline, Intarcia, Medtronic, Neovasc, Novo Nordisk, Provention Bio and ReCor and consulting activities and research funding to his institution from AbbVie, AstraZeneca, CSL Behring, Eli Lilly, Esperion and Novartis
On the other hand, when patients discontinue GLP-1s, their weight regain is typically incremental to how quickly and how much they lost while taking the medicine, Buie said
Multiple experts have established a direct link between poor gut health and autoimmune diseases which Hashimotos represents
It can also support the immune system and jumpstart detox processes through binding free radicals
Anyone with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome should not use GLP-1 medications